FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> Novartis
Syndicate content

Zhejiang Tianyuan News

Most Popular Zhejiang Tianyuan Story

Novartis gains majority ownership of Zhejiang Tianyuan

In an effort to expand its presence in China, Novartis ($NVS) has purchased an 85 percent majority stake of vaccine maker Zhejiang Tianyuan. The Chinese company produces flu, meningococcal, Japanese Read more...

Latest Headlines